Providers' beliefs about the effectiveness of the HPV vaccine in preventing cancer and their recommended age groups for vaccination: Findings from a provider survey, 2012 |
| |
| Institution: | 1. Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Highway NE, MS F76, Atlanta, GA 30341, USA;2. Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA 30322, USA;1. Division of Family Medicine, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden;2. Academic Primary Healthcare Centre, Stockholm County Council, Huddinge, Sweden;3. Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden;4. Public Healthcare Services Committee Administration, Stockholm County Council, Box 6909, SE-102 39 Stockholm, Sweden;5. Medical Management Centre, Department of Learning, Informatics, Management and Ethics, Karolinska Institutet, Berzelius väg 3, SE-17177 Stockholm, Sweden;1. Office on Smoking and Health, US Centers for Disease Control and Prevention, Atlanta, GA, USA;2. Center for Global Health, US Centers for Disease Control and Prevention, Atlanta, GA, USA;3. Office of Tobacco Control, Chinese Center for Disease Control and Prevention, Beijing, PR China;1. Department of Epidemiology, Health Economics and Public Health, UMR1027 INSERM–Toulouse University, Toulouse University Hospital (CHU), Toulouse, France;2. Department of Epidemiology and Public Health, INSERM UMR744, Pasteur Institute of Lille, Lille Nord de France University–UDSL, Lille, France;3. Department of Epidemiology and Public Health, EA 3430, FMTS, Strasbourg University, Strasbourg, France;4. Department of Public Health, Strasbourg University Hospital, Strasbourg, France;5. Department of Cardiology B, Toulouse University Hospital, Toulouse, France;1. Center of Research in Childhood Health (RICH), Institute of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark;2. The Center of Inflammation and Metabolism (CIM) and The Center for Physical Activity Research (CFAS) at Rigshospitalet, Copenhagen, The Danish Diabetes Academy, Odense, Denmark;3. SDU Muscle Research Cluster (SMRC), Institute of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark;4. Department of Sports Medicine, Norwegian School of Sport Sciences, Oslo, Norway;1. Department of Preventive Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, CA, United States;2. MacDiarmid Institute for Advanced Materials and Nanotechnology, Department of Electrical and Computer Engineering, University of Canterbury, Christchurch, New Zealand;3. Department of Dermatology, Keck School of Medicine of the University of Southern California, Los Angeles, CA, United States |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
